Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 16 symbols : Jnj save search
Insights on the AI in Healthcare Global Market to 2025 - by Sections, Diagnosis, End-user and Geography
Published: 2021-04-16 (Crawled : 21:00) - prnewswire.com
IBM | $184.1 1.05% -5.69% 7M
|
Technology Services
| Email alert
Add to watchlist
INTC | $34.49 0.61% 0.61% 49M
|
Electronic Technology
| Email alert
Add to watchlist
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
| Email alert
Add to watchlist
AMZN S | $176.57 -1.65% -3.18% 32M
|
Retail Trade
| Email alert
Add to watchlist
NVDA | News | $796.78 -3.33% -4.92% 50M
|
Electronic Technology
| Email alert
Add to watchlist
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
MSFT | News 4 | $408.94 0.34% 0.33% 14M
|
Technology Services
| Email alert
Add to watchlist
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
| Email alert
Add to watchlist
diagnostic
Coronavirus (COVID-19) Update: April 16, 2021
Published: 2021-04-16 (Crawled : 19:38) - fda.gov
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
| Email alert
Add to watchlist
covid covid-19
APEX Biologix Expands its Footprint Through Investment by Desert Highlands Regenerative
Published: 2021-04-16 (Crawled : 17:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
J&J Wanted to Collab on Blood Clotting Investigation, but Pfizer and Moderna Declined
Published: 2021-04-16 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
blood
Solution Needed to Address Increase in Vaccine Hesitancy for Medical, Religious, Philosophical Reasons Fueled by Johnson & Johnson COVID Vaccine Pause
Published: 2021-04-16 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
covid vaccine
J&J Wanted to Collab on Blood Clotting Investigation, but Pfizer and Moderna ...
Published: 2021-04-16 (Crawled : 17:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
blood
Solution Needed to Address Increase in Vaccine Hesitancy for Medical, Religious, Philosophical Reasons Fueled by Johnson & Johnson COVID Vaccine Pause
Published: 2021-04-16 (Crawled : 15:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
covid vaccine
Janssen Showcases Phase 2 Nipocalimab (M281) Data in Adults with Generalized Myasthenia Gravis (gMG) at the 2021 American Academy of Neurology Virtual Meeting
Published: 2021-04-16 (Crawled : 12:15) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
phase 2
Prescience Point Capital Management to Nominate Four Highly Qualified Director Candidates to MiMedx Board at 2021 Annual Meeting
Published: 2021-04-16 (Crawled : 12:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
MDXG | $6.44 -1.08% -1.09% 650K
|
Health Technology
|
| O: 0.57%
H: 0.89%
C: -5.74%
ENDP | News | $0.2926 -9.6%
|
Health Technology
|
| O: 0.99%
H: 2.95%
C: 2.45%
Ehave Prepares to Launch Ketamine Clinical Trials Using Brain Scientific’s Brain Mapping Technology
Published: 2021-04-16 (Crawled : 12:00) - globenewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
clinical trials technology trial ketamine train
Middlefield Canadian Income PCC - Annual Financial Report
Published: 2021-04-16 (Crawled : 07:00) - globenewswire.com
TU | $16.08 -0.8% 0.0% 2.4M
|
Communications
|
| O: 0.29%
H: 1.12%
C: 1.07%
SLF 4 d | $51.7 -0.29% 0.0% 450K
|
Finance
|
| O: 1.01%
H: 0.38%
C: 0.13%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.59%
H: 0.73%
C: 0.56%
ENB 3 d | $35.66 0.68% 0.39% 8M
|
Industrial Services
|
| O: 0.51%
H: 0.0%
C: -0.48%
CM | $47.54 -1.0% 0.0% 810K
|
Finance
|
| O: 0.22%
H: 0.6%
C: 0.47%
BMO | $92.84 -1.05% 0.0% 350K
|
Finance
|
| O: 0.44%
H: 0.1%
C: -0.16%
T | $16.81 1.88% 0.0% 74M
|
Communications
|
| O: 0.54%
H: 0.4%
C: 0.13%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.56%
H: 0.99%
C: 0.39%
MSFT | News 4 | $408.94 0.34% 0.33% 14M
|
Technology Services
|
| O: -0.01%
H: 0.59%
C: 0.49%
financial report report
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.